Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -22.97 Million | -23.2 Million | -9.9 Million | -32.9 Thousand |
| Net Income | -47.94 Million | -34.61 Million | -30.42 Million | -485.19 Thousand |
| Depreciation & Amortization | 3.12 Million | 3.29 Million | 2.98 Million | - |
| Deferred income taxes | - | -5.77 Million | -8.28 Million | - |
| Stock-based compensation | 2.64 Million | 3.03 Million | 4.8 Million | 862.76 Thousand |
| Change in working capital | 3.55 Million | 3.94 Million | 2.25 Million | 92.02 Thousand |
| Other non-cash items | 15.65 Million | 6.9 Million | 18.76 Million | 268.22 Thousand |
| Investing Cash Flow | - | -1.53 Million | -28.36 Million | - |
| Investments in PPE | -5.00 | -1.53 Million | -28.33 Million | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | -40 Thousand | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | -1.48 Million | 8831.00 | - |
| Financing Cash Flow | 29.87 Million | 9.21 Million | 65.11 Million | 60 Thousand |
| Debt repayment | -2.2 Million | - | -69 Thousand | -59 Thousand |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | -854.76 Thousand | -4.83 Million | - |
| Common Stock Issuance | 28.11 Million | 9.21 Million | 70 Million | 1000.00 |
| Other Financing Activities | 27.67 Million | 854.76 Thousand | 10 Thousand | 144 Thousand |
| Accounts receivables | 3.48 Million | 1.5 Million | -50.13 Thousand | -6347.00 |
| Accounts payables | 3.49 Million | 2.34 Million | 2.53 Million | 98.37 Thousand |
| Inventory | - | - | - | - |
| Other working capital | 73.87 Thousand | 95.68 Thousand | -228.81 Thousand | - |
| Cash at beginning of period | 11.69 Million | 26.97 Million | 27.09 Thousand | - |
| Cash at end of period | 18.57 Million | 11.69 Million | 26.97 Million | 27.09 Thousand |
| Capital Expenditure | -5.00 | -1.53 Million | -28.33 Million | - |
| Effect of forex changes on cash | -25.03 Thousand | 234.64 Thousand | 127.37 Thousand | - |
| Net cash flow / Change in cash | 6.87 Million | -15.28 Million | 26.95 Million | 27.09 Thousand |
| Free Cash Flow | -22.97 Million | -24.73 Million | -38.24 Million | -32.9 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -47.94 Million | -11.59 Million | -11.59 Million | -24.75 Million | -12.37 Million | -22.05 Million |
| Depreciation & Amortization | 3.12 Million | 778.31 Thousand | 778.31 Thousand | 1.56 Million | 784.83 Thousand | 4.74 Million |
| Deferred income taxes | - | - | - | - | - | -11.03 Million |
| Stock-based compensation | - | 576.2 Thousand | 576.2 Thousand | 743.88 Thousand | 743.88 Thousand | 791.4 Thousand |
| Change in working capital | - | 1.77 Million | 1.77 Million | - | - | 800.85 Thousand |
| Other non-cash items | 28.09 Million | 2.86 Million | 2.86 Million | 14.55 Million | 4.96 Million | 15.63 Million |
| Investing Cash Flow | - | - | - | -5779.00 | - | -1.45 Million |
| Investments in PPE | - | - | - | - | - | -1.45 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -742.68 Thousand |
| Financing Cash Flow | 29.87 Million | 13.94 Million | 13.94 Million | 1.97 Million | 989.66 Thousand | -18.73 Thousand |
| Debt repayment | -2.2 Million | -2.2 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -365.00 |
| Common Stock Issuance | 28.11 Million | 26.01 Million | - | 2.09 Million | - | -18.73 Thousand |
| Other Financing Activities | -437 Thousand | 13.94 Million | 13.94 Million | -117 Thousand | 989.66 Thousand | -9000.00 |
| Accounts receivables | - | 1.74 Million | 1.74 Million | - | - | 753.01 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 36.93 Thousand | 36.93 Thousand | - | - | 47.84 Thousand |
| Cash at beginning of period | 11.69 Million | 1.89 Million | - | 11.69 Million | - | 24.24 Million |
| Cash at end of period | 18.57 Million | 18.57 Million | 8.34 Million | 1.89 Million | -4.9 Million | 11.69 Million |
| Capital Expenditure | - | - | - | - | - | -1.45 Million |
| Effect of forex changes on cash | - | -6739.00 | -6739.00 | -5779.00 | -5779.00 | 47.18 Thousand |
| Net cash flow / Change in cash | 6.87 Million | 16.68 Million | 8.34 Million | -9.8 Million | -4.9 Million | -12.54 Million |
| Free Cash Flow | -22.97 Million | -5.6 Million | -5.6 Million | -11.77 Million | -5.88 Million | -12.62 Million |
3707
IMPUY
UBQ
KRSA3
BMN
HPCRF